American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PROCEPT BioRobotics Corp (PRCT)

$19.96 -0.35% NASDAQ: PRCT · 15-min delayed

SAN JOSE, California
Public · NASDAQ: PRCT
888 employees

Visit website Follow

$950.0MMarket cap

$308.1MRevenue · FY2025

-$95.6MNet income

888Employees

PRCTNASDAQ

2021IPO

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: PRCT
Employees: 888
IPO date: Sep 15, 2021
Headquarters: 150 BAYTECH DRIVE
SAN JOSE, California 95134
Phone: (650) 232-9832
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: PRCT Nasdaq
SEC CIK: 1588978
EIN: 260199180
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show PROCEPT BioRobotics Corp’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/procept-biorobotics-corp/"><img src="https://americancompanies.com/badge/procept-biorobotics-corp.svg" alt="PROCEPT BioRobotics Corp — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow PROCEPT BioRobotics Corp and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $308.1M
Net income: -$95.6M
Total assets: $508.1M
Market cap: $950.0M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: PRCT

$19.96 -0.35%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$16.69 $39.15

52-week range

Market cap: $950.0M
Shares outstanding: 47.6M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Sep 15, 2021

PROCEPT BioRobotics Corp (PRCT) Stock Price

Reported a net loss of $95.6M in FY2025.
Trading 49% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review PROCEPT BioRobotics Corp.

Write a review

Newsroom

News about PROCEPT BioRobotics Corp

LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation GlobeNewswire Inc. · 2026-09-30 · negative Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf GlobeNewswire Inc. · 2026-09-24 · negative Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit GlobeNewswire Inc. · 2026-09-21 · negative Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026 GlobeNewswire Inc. · 2026-09-21 · negative INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026 GlobeNewswire Inc. · 2026-09-19 · negative PROCEPT DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – PRCT GlobeNewswire Inc. · 2026-09-19 · negative

News & sentiment via Polygon.io

FAQ

PROCEPT BioRobotics Corp: frequently asked questions

Is PROCEPT BioRobotics Corp an American company?

PROCEPT BioRobotics Corp is a US-based company headquartered in San Jose, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is PROCEPT BioRobotics Corp headquartered?

PROCEPT BioRobotics Corp is headquartered in San Jose, California, United States.

Is PROCEPT BioRobotics Corp publicly traded?

Yes — PROCEPT BioRobotics Corp is a publicly traded company. Its stock trades under the ticker symbol PRCT on the NASDAQ.

What does PROCEPT BioRobotics Corp do?

PROCEPT BioRobotics Corp is an American Medical Devices company in the Health & Beauty sector.

Explore